NM_004860.4:c.1685G>C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004860.4(FXR2):c.1685G>C(p.Gly562Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000112 in 1,613,376 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004860.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FXR2 | ENST00000250113.12 | c.1685G>C | p.Gly562Ala | missense_variant | Exon 14 of 17 | 1 | NM_004860.4 | ENSP00000250113.7 | ||
FXR2 | ENST00000704984.1 | c.1904G>C | p.Gly635Ala | missense_variant | Exon 14 of 17 | ENSP00000516064.1 | ||||
MPDU1 | ENST00000423172.6 | c.*266C>G | 3_prime_UTR_variant | Exon 6 of 6 | 2 | ENSP00000414071.2 | ||||
MPDU1 | ENST00000584378.5 | c.*244C>G | downstream_gene_variant | 4 | ENSP00000462839.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151684Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 248808Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135010
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461692Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 727122
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151684Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74056
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1685G>C (p.G562A) alteration is located in exon 14 (coding exon 14) of the FXR2 gene. This alteration results from a G to C substitution at nucleotide position 1685, causing the glycine (G) at amino acid position 562 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at